Julie Rovner has spent over forty years patrolling the hallways of power in Washington, documenting the intricate and often frustrating evolution of American healthcare. As the chief Washington correspondent for KFF Health News and the host of the "What the Health?" podcast, she has
The traditional American employer-sponsored healthcare model, long criticized for its opacity and escalating costs, is currently facing a fundamental challenge as tech-driven innovators consolidate their power to offer direct alternatives to legacy carriers. Included Health's recent
Behind the closed doors of a high-stakes forum in Chicago, the carefully manicured façade of the American healthcare industry finally began to crumble under the weight of unprecedented institutional scrutiny. For decades, the sector has relied on a series of polite fictions to mask a reality of
The sudden realization that a routine medical procedure could cost more than a luxury vehicle often forces patients into a frantic search for alternatives that the standard healthcare model rarely admits exist. For Ronmel Rangel, a 63-year-old with a background in management, a diagnosis of an
The landscape of British biotechnology has undergone a seismic shift as total investment levels soared to heights not witnessed since the start of the decade, signaling a robust recovery and a new era of scientific confidence. This surge reflects a maturation of the sector where high-risk research
The traditional landscape of healthcare investment is undergoing a seismic transformation where the mere possession of capital is no longer a sufficient guarantor of market-beating performance in an increasingly crowded venture ecosystem. For decades, the industry relied on a predictable flow of
